Health & Biotech
Opyl (ASX: OPL) are a Melbourne based company with client service and development teams in both Australia and the US.
Opyl provides biopharma and health organisations access to emerging AI-assisted technologies and professional guidance to understand and improve healthcare design, development and delivery.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Stockhead TV
Healthcare: Clinical trial inefficiencies and the role of artificial intelligence
Health & Biotech
Introducing Opin, Opyl’s AI platform that recruits clinical trial patients from around the world
Health & Biotech
Opyl makes a strategic board recruitment as it looks to commercialise its product offerings
News
Last Orders: ASX slides again – falls below 7,000 mark
Tech
Opyl completes major milestone on clinical trials platform, on track for go-live in May
Tech
Opyl taking two steps to revolutionise clinical trials this year
Tech
Opyl delivers maiden profit as first-half revenue jumps 33%
Experts
Scopo’s health powerplays: Nanosonics plays out ‘really well’ for Morgans
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Tech
Opyl preps key March quarter launch as the clinical trial recruitment market heats up
Experts
ScoPo’s Powerplays: Despite recent losses, healthcare is a great sector to be in
Stockhead TV
How can artificial intelligence revolutionise healthcare?
Tech
Opyl snares ex-Cochlear executive as medtech’s platforms approach launch
Health & Biotech
AI in healthcare: 3 ASX small caps discuss their recipe for success
Experts
ScoPo’s health powerplays: Pot stocks get a boost
News
Rise and Shine: What you need to know before the ASX opens
Experts
